PET imaging that helps detect dementia-related amyloid plaques significantly influences the clinical management of patients, a new study reports.
Self-propagating amyloid and tau act as prions in the pathology of Alzheimer's disease. Higher levels of the prions in human brain samples were strongly correlated with early onset of Alzheimer's and death at a younger age.
A new study report omega 3 and omega 6 unsaturated fatty acids are significantly decreased in the brains of people with Alzheimer's.
Using a technique called parabiosis on pairs of mice, researchers discover what they call 'cancer like mobility' of amyloid beta, reporting it can travel to the brain from other parts of the body.
A new study reports amyloid beta induces a strong inflammatory response, destroying the blood-CSF barrier.
Researchers have discovered a potential drug which can force BACE into different parts of a cell, reducing its ability to produce amyloid beta.
Researchers report a drug developed to target amyloid plaques in those with Alzheimer's does not significantly slow cognitive decline.
Researchers report memantine, an FDA approved drug, may not only alleviate symptoms of mild Alzheimer's disease, but could also prevent progression of the disease if used before symptoms appear.